Table 3 The number of users of thyroid hormones dispensed 1 year before and after the first dispense of LDN. The groups are stratified based on the number of LDN dispenses: LDN × 1 (N = 260), LDN × 2–3 (N = 198) and LDN × 4+ (N = 440). LDN: Low dose naltrexone
Number of users | Difference | ||||||
|---|---|---|---|---|---|---|---|
Before | After | ||||||
N | % | N | % | % points | 95%CI | p | |
Levothyroxine (LT4) | |||||||
LDN × 1 | 243 | (93.5) | 240 | (92.3) | −1.2 | (−3.7 to 1.3) | 0.366 |
LDN × 2–3 | 191 | (96.5) | 187 | (94.4) | −2.0 | (−4.0 to −0.1) | 0.045 |
LDN × 4+ | 420 | (95.5) | 420 | (95.5) | 0.0 | (−1.5 to 1.5) | 1.000 |
Triiodothyronine (T3) | |||||||
LDN × 1 | 28 | (10.8) | 24 | (9.2) | −1.5 | (−4.1 to 1.1) | 0.248 |
LDN × 2–3 | 15 | (7.6) | 11 | (5.6) | −2.0 | (−5.1 to 1.1) | 0.206 |
LDN × 4+ | 51 | (11.6) | 55 | (12.5) | 0.9 | (−1.2 to 3.0) | 0.394 |